Chemical activators of Olr1397 can facilitate its functional activation through various biochemical pathways. Calcium ionophore A23187 and Ionomycin are two such activators that increase intracellular calcium levels, a pivotal signal that can activate Olr1397 by promoting its interaction with calcium-dependent protein kinases. These kinases can phosphorylate Olr1397, which is a key regulatory modification for the activation of many proteins. Similarly, Phorbol 12-myristate 13-acetate (PMA) and 4-β-Phorbol serve as activators of protein kinase C (PKC). Upon activation, PKC phosphorylates target proteins, and Olr1397 can be one such target. This phosphorylation serves as an on-switch for Olr1397, enabling it to carry out its cellular functions.
Continuing along this line, other activators like Forskolin and 8-Bromo-cAMP specifically target the cAMP-dependent pathway by activating adenylyl cyclase and PKA, respectively. The rise in cAMP levels and subsequent PKA activation lead to the phosphorylation of Olr1397, signifying its activation. Oleoyl-L-carnitine, although not directly involved in phosphorylation, can influence the activation of Olr1397 by altering fatty acid metabolism and energy status within the cell, which can have downstream effects on proteins regulated by these metabolic cues. Okadaic acid contributes to the activation of Olr1397 by inhibiting phosphatases such as PP1 and PP2A, preventing Olr1397 dephosphorylation and thus maintaining it in an active state. In contrast, (S)-(+)-Bay K 8644 directly increases calcium influx through L-type calcium channels, again potentially leading to the activation of Olr1397 via calcium-sensitive kinases. 1-Oleoyl-2-acetyl-sn-glycerol (OAG) mimics diacylglycerol to activate PKC, which can then phosphorylate and activate Olr1397. Bisindolylmaleimide I, though a PKC inhibitor, can result in the compensatory activation of alternative kinases that may target and activate Olr1397. Lastly, Dibutyryl cAMP, another cAMP analog, activates PKA, which can phosphorylate Olr1397, ensuring its activation and function within cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore A23187 facilitates the influx of calcium ions into the cell, which can activate Olr1397 by increasing intracellular calcium levels, a signal that is known to directly activate various cellular proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which then can phosphorylate Olr1397, leading to its activation, as PKC-mediated phosphorylation is a well-established mechanism for protein activation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that directly activates PKA. Once activated, PKA can phosphorylate Olr1397, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore which increases intracellular calcium concentration and can activate calcium-dependent protein kinases that may phosphorylate and activate Olr1397. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins, which could result in the activation of Olr1397 by preventing its dephosphorylation. | ||||||
1-Oleoyl-2-acetyl-sn-glycerol (OAG) | 86390-77-4 | sc-200417 sc-200417A | 10 mg 50 mg | $119.00 $453.00 | 1 | |
OAG is a diacylglycerol analog that activates PKC, and subsequently, PKC can phosphorylate and activate Olr1397. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a potent and selective inhibitor of PKC, but its use can lead to compensatory activation of other kinases which could then phosphorylate and activate Olr1397. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cell-permeable cAMP analog that activates PKA, and activated PKA has the potential to phosphorylate and activate Olr1397. | ||||||